Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0DR4W
|
|||
Former ID |
DIB001030
|
|||
Drug Name |
MyoCell SDF-1
|
|||
Synonyms |
Autologous skeletal myoblast therapy (SDF-1, cardiovascular disease), Bioheart
Click to Show/Hide
|
|||
Indication | Heart failure [ICD-11: BD10-BD13; ICD-10: I50, I50.9; ICD-9: 428] | Phase 3 | [1] | |
Company |
Bioheart
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Stromal cell-derived factor 1 (CXCL12) | Target Info | Modulator | [2] |
KEGG Pathway | Cytokine-cytokine receptor interaction | |||
Chemokine signaling pathway | ||||
NF-kappa B signaling pathway | ||||
Axon guidance | ||||
Leukocyte transendothelial migration | ||||
Intestinal immune network for IgA production | ||||
Pathways in cancer | ||||
Rheumatoid arthritis | ||||
NetPath Pathway | IL-7 Signaling Pathway | |||
TWEAK Signaling Pathway | ||||
Panther Pathway | Axon guidance mediated by Slit/Robo | |||
Pathway Interaction Database | CXCR4-mediated signaling events | |||
Syndecan-4-mediated signaling events | ||||
HIF-1-alpha transcription factor network | ||||
Reactome | Nuclear signaling by ERBB4 | |||
Chemokine receptors bind chemokines | ||||
G alpha (i) signalling events | ||||
WikiPathways | EV release from cardiac cells and their functional effects | |||
Signaling by ERBB4 | ||||
Allograft Rejection | ||||
miR-targeted genes in muscle cell - TarBase | ||||
miR-targeted genes in lymphocytes - TarBase | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021307) | |||
REF 2 | Stromal cell-derived factor-1 (SDF-1): homing factor for engineered regenerative medicine. Expert Opin Biol Ther. 2011 Feb;11(2):189-97. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.